What Happened to PharmEasy? | India’s Health-Tech Giant Explained
PharmEasy: From $5.6 Billion Valuation to a Massive Comeback? | Business Case StudyPharmEasy was once valued at around $5.6 billion, making it one of India’s biggest health-tech success stories. But within a few years, the company lost more than 90% of its peak valuation, accumulated massive debt, reported huge losses, and eventually had to withdraw its proposed ₹6,250 crore IPO.
Publish Date
26 October 2026Category
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Registrations & Certifications
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
Address
MiQB, Plot 23, Sector 18 Maruti, Industrial Development Area, near Motherson Sumi Systems Limited, Gurugram, Haryana 122015
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
